This content is provided by Superpower Health for educational and informational purposes only. The ingredients discussed on this page are cosmetic ingredients regulated under FDA cosmetics law. Silk peptide ingredients are not evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. This page is not a substitute for dermatological or medical advice.
Silk peptides are derived from silkworm cocoons — a textile processing byproduct that turned out to have measurable biological properties relevant to skin hydration, UV protection, wound healing, and hair conditioning.
Key Takeaways
- Compounds covered: Sericin (silk sericin), fibroin (silk fibroin), hydrolyzed silk, silk peptide hydrolysates
- Goal area: Skin moisturization and antioxidant protection; hair conditioning and moisture retention
- Evidence range: Safety established by CIR Expert Panel (Fiume et al., 2020); multiple in vitro studies for antioxidant, anti-melanogenesis, and fibroblast-associated activity; limited completed RCTs in humans for cosmetic silk peptide endpoints
- Regulatory range: Cosmetic ingredients under FDA cosmetics law; not FDA-approved drugs; no prescription required
- Key biomarkers: No bloodwork required for topical cosmetic use; ferritin, vitamin B12, and hs-CRP relevant for the underlying biology of skin and hair changes
- As of April 2026: Silk peptide ingredients (hydrolyzed silk, sericin, fibroin) are classified as cosmetic ingredients and are not FDA-approved for any therapeutic indication.
- Bottom line: Silk peptides have a well-established safety profile and multiple documented biological properties; clinical trial data in humans for specific cosmetic endpoints is less developed than in vitro evidence suggests.
Understanding Silk Peptides: Origin and Biological Properties
The silkworm cocoon is an engineering achievement in biological terms: a continuous protein thread strong enough to protect a developing moth, produced by glands that secrete two structurally distinct proteins in a precise layered architecture. When the textile industry processes silkworm cocoons to produce raw silk, it discards the outer protein layer — sericin — which was long considered a waste product because it interferes with the luster of the final fiber. The observation that this "waste" protein has measurable cosmetic biological activity redirected attention to what sericin and the underlying fibroin protein actually do.
Kundu and colleagues, in a 2012 review in Waste Management & Research, detailed the potential cosmetic and biomedical applications of silk sericin recovered as a textile industry by-product: sericin is a processing waste product of the silk textile industry that was found to have cosmetic value. That framing matters because it explains why sericin research developed in conjunction with industrial byproduct utilization rather than as a primary pharmaceutical development program — the evidence base reflects that origin, being more extensive in material science and in vitro biology than in controlled clinical trials.
Silk proteins are composed predominantly of serine, glycine, and alanine. Sericin is particularly serine-rich — serine is a hydroxyl amino acid with strong water-binding capacity, which directly underlies sericin's moisture-retention properties. Fibroin's repeating Gly-Ala-Gly-Ala-Ser sequence forms stable beta-sheet crystalline domains, as established by Zhou and colleagues in a classic 2001 Proteins study, characterizing silk fibroin's amino acid sequence and beta-sheet architecture. This crystalline structure gives fibroin-derived peptides their distinctive film-forming and moisture-barrier properties in cosmetic applications.
Molecular weight determines how these properties manifest in formulations. Lamboni and colleagues, in a 2020 Journal of Pharmaceutical and Biomedical Analysis paper, chromatographically profiled silk sericin by molecular weight fractions for cosmetic use, establishing that lower-molecular-weight fractions penetrate skin more effectively while higher-molecular-weight fractions form surface films. Kundu and colleagues, in a 2014 Progress in Polymer Science review, reviewed isolation and processing methods for silk proteins, noting that different processing approaches yield cosmetic-grade fractions with distinct molecular properties and biological activities.
Silk Peptides: A Quick Comparison
The following silk protein ingredients have documented biological properties relevant to hair and skin. They are ordered from most-documented to least in terms of published evidence for specific cosmetic applications.
-
Compound: Sericin (silk sericin / hydrolyzed sericin)
Mechanism for skin: Moisture binding via serine-rich hydrophilic structure; antioxidant via free-radical scavenging; anti-melanogenesis via tyrosinase inhibition in cellular models; anti-inflammatory via cytokine modulation in cellular models; in vitro fibroblast activation (collagen production observed in cultured fibroblasts, not demonstrated in human skin)
Evidence: Multiple in vitro and preclinical studies; limited human clinical data (one burn wound clinical study, Aramwit et al. 2013); CIR safety panel review (2020)
FDA status: Cosmetic ingredient; not FDA-approved for any indication
SP availability: Not available through Superpower
Route: Topical -
Compound: Fibroin (silk fibroin / hydrolyzed silk)
Mechanism for skin/hair: Film formation via beta-sheet structure; moisture barrier; hair surface conditioning via adsorption to fiber; fibroblast proliferation support in wound contexts
Evidence: Structural studies (Zhou et al., 2001); fibroblast proliferation data (Kamalathevan et al., 2018 systematic review); hair conditioning data (Mota et al., 2025)
FDA status: Cosmetic ingredient; not FDA-approved for any indication
SP availability: Not available through Superpower
Route: Topical -
Compound: Silk sericin-fibroin combination
Mechanism: Additive skin benefits; Byram and colleagues 2024 showed bioactive fibroin-sericin films produce additive outcomes in skin tissue engineering contexts
Evidence: Preclinical tissue engineering data; formulation context primarily
FDA status: Cosmetic ingredient category
SP availability: Not available through Superpower
Route: Topical
Silk Peptides: Individual Property Profiles
Silk peptides are not a single compound but a class of protein-derived ingredients with distinct molecular profiles depending on protein source, processing method, and molecular weight fraction. The evidence base reflects this variability.
Moisture retention and film formation
Sericin's moisture-retaining properties derive directly from its serine-rich composition. Serine's hydroxyl side chain forms hydrogen bonds with water molecules, creating a hygroscopic film on the skin or hair surface that resists transepidermal water loss. This is a physical chemistry property, not a drug effect — it is why sericin has been described as a humectant.
For hair specifically, Mota and colleagues published work in ACS Biomaterials Science & Engineering in 2025 characterizing a recombinant silk-elastin-keratin structural protein copolymer (SELP::KP), demonstrating that the copolymer halved the combing force required for hair and increased Young's modulus by 34.9% in mechanical testing of virgin hair — the primary measure of hair-conditioning efficacy. Min and colleagues, in their 2018 International Journal of Biological Macromolecules study, demonstrated excellent moisture absorption and retention for a quaternary ammonium chitosan-silk fibroin peptide copolymer relevant to hair conditioning formulations. [In vitro / material characterization]
For skin, Saad and colleagues published a comprehensive 2023 review in the International Journal of Biological Macromolecules covering sericin's extraction, structure, biochemical properties, and cosmetic applications. Aramwit, in a foundational 2016 review in BioMed Research International, reviewed silkworm sericin properties across cosmetic, wound healing, and skin care applications, establishing the multi-functional profile of sericin as a cosmetic ingredient.
Antioxidant and UV protection properties
Multiple studies document sericin's antioxidant activity. Aramwit and colleagues, in a 2022 Antioxidants paper, reported that silk sericin reduced UV-induced oxidative stress markers in keratinocytes in vitro, with keratinocytes being the primary skin surface cells. Lee and colleagues, in a 2023 Korean Journal of Physiology & Pharmacology paper, showed gamma-irradiated silk sericin and fibroin demonstrate anti-oxidation and anti-inflammatory effects in H₂O₂-induced HaCaT cells — a widely used keratinocyte stress model. [In vitro]
The antioxidant potency of sericin depends on its source. Kundu and colleagues, in a 2017 Free Radical Biology & Medicine review, compared antioxidant potential of mulberry and non-mulberry silk sericin, finding that non-mulberry silkworm sericin (such as Antheraea mylitta) shows higher antioxidant activity than standard Bombyx mori mulberry sericin. Product labeling does not routinely specify silkworm species, which creates variability in the antioxidant activity delivered by different "silk peptide" products.
Anti-melanogenesis and brightening activity
The anti-melanogenesis evidence is among the more commercially relevant aspects of sericin research, given consumer interest in skin brightening. Three papers provide the primary evidence hierarchy:
Cherdchom and colleagues, in a 2021 paper in the Journal of Traditional and Complementary Medicine, demonstrated that urea-extracted silk sericin reduced melanin content and cellular tyrosinase activity more effectively than kojic acid in B16F10 melanoma cells — positioning sericin competitively against the standard cosmetic brightening reference compound. [In vitro]
Aramwit and colleagues, in a 2019 Photochemical & Photobiological Sciences study, reported that silk sericin inhibited UV-induced melanogenesis in cellular models. Rattanapak and colleagues, in a 2022 International Journal of Biological Macromolecules study, used proteomics to examine Thai silk sericin's protective effects against UVA-induced phototoxicity and melanogenesis in primary melanocytes, adding mechanistic depth to the anti-melanogenesis claim. [In vitro]
No controlled human clinical trial evaluating sericin specifically for skin brightening or hyperpigmentation cosmetic applications has been published as of April 2026. The in vitro evidence is consistent but does not establish clinical efficacy in human skin.
Skin wound healing and fibroblast activation
The wound healing evidence for sericin is among the most developed in terms of biological mechanism. Zhao and colleagues published a state-of-the-art review in Macromolecular Bioscience in 2024 on silk sericin's effects on skin wound healing, covering antibacterial, antioxidant, anti-inflammatory, and angiogenic properties — a comprehensive biological profile. Aramwit and colleagues, in a 2010 International Journal of Molecular Sciences paper, demonstrated that silk sericin promotes collagen production in cultured fibroblasts in a concentration-dependent manner, with heat-extracted sericin producing the strongest effect — foundational data connecting sericin to collagen-stimulating activity. [In vitro]
The most direct human safety evidence comes from a clinical study by Aramwit and colleagues in Archives of Dermatological Research in 2013, showing silk sericin is safe and beneficial in burn wound treatment when added to silver sulfadiazine cream — the first published human clinical evidence of topical sericin's safety and wound-relevant benefit. [Clinical pilot study]
For fibroin's role in wound and skin tissue: Kamalathevan and colleagues published a systematic review of silk-based biomaterials in cutaneous wound healing in Advances in Skin & Wound Care in 2018 covering silk fibroin scaffold performance across wound healing models, showing SF-based materials promote fibroblast proliferation and adhesion in in vitro models. Byram and colleagues, in a 2024 Biomedical Materials paper, characterized bioactive self-assembling silk fibroin-sericin films for skin tissue engineering, showing that combined fibroin-sericin produces additive outcomes — supporting the rationale for products that include both proteins.
Stradczuk-Mazurek and colleagues published the most current clinical-adjacent review in Macromolecular Bioscience in 2025 reviewing silk sericin in dermatological diseases from preclinical studies through future clinical applications, contextualizing where clinical translation currently stands.
Anti-inflammatory activity
Zhao and colleagues (2024), Aramwit and colleagues (2018), and Lee and colleagues (2023) all documented anti-inflammatory properties of sericin in cellular models. Rao and colleagues, in a 2022 Journal of Food Biochemistry study, showed covalent flavonoid conjugation with silk sericin hydrolysate enhances anti-inflammatory and antioxidant properties, pointing toward sericin's potential as a functional carrier in cosmetic formulations that can be enhanced by conjugation with other bioactive molecules.
Regulatory Status at a Glance
As of April 2026, the following regulatory positions apply.
- Hydrolyzed silk / silk amino acids: Cosmetic ingredient; not FDA-approved for any indication; assigned standardized INCI (International Nomenclature of Cosmetic Ingredients) names for cosmetic labeling; reviewed as safe for use in cosmetic products by the CIR Expert Panel (Fiume et al., 2020)
- Sericin (silk sericin): Same status as above
- Fibroin (silk fibroin / hydrolyzed silk fibroin): Same status as above
- Silk fibroin in biomedical scaffolding or wound dressings: FDA-regulated as a medical device, not as a cosmetic; this is a distinct product category from cosmetic silk peptides and requires separate regulatory review
Considerations When Evaluating Silk Peptide Products
The silk peptide cosmetics market is broad but poorly standardized in terms of ingredient specification, which creates significant variability in what different products deliver.
Protein fraction matters: Sericin and fibroin have different biological activities — sericin for antioxidant and anti-inflammatory properties, fibroin for film formation and hair conditioning. Products that specify whether they contain sericin, fibroin, or hydrolyzed silk (a mixture) and at what concentration provide more useful information than those that use only the generic "silk proteins" label.
Molecular weight affects function: Lamboni and colleagues' 2020 fractionation data established that low-molecular-weight sericin penetrates skin while high-molecular-weight fragments remain at the surface. Products used for anti-inflammatory or collagen-stimulating effects require low-MW fractions; products used for moisture-film formation may use higher-MW fractions. This is rarely specified on cosmetic labels.
Silkworm species affects antioxidant potency: The Kundu and colleagues 2017 review documented that non-mulberry silkworm sericin has higher antioxidant activity than standard Bombyx mori sericin. Products that specify their silk source provide better-characterized ingredient claims.
Evidence translation gap: The biological properties documented in vitro — antioxidant, anti-melanogenesis, fibroblast stimulation — were established in controlled cellular conditions. Translation to observable cosmetic outcomes in human skin depends on delivery efficiency, concentration, formulation stability, and the specific skin biology of the individual. Charoenwiratthinun and colleagues, in a 2022 Pharmaceuticals paper, developed a finished cosmetic formulation combining sericin hydrogel with plant extracts for anti-hyperpigmentation and anti-aging applications — illustrating the translational complexity between ingredient evidence and finished product performance.
This is not an exhaustive list. A dermatologist can provide guidance on formulation selection based on specific skin conditions and goals.
Safety Considerations
Silk peptide ingredients have a well-established cosmetic safety profile. The CIR Expert Panel reviewed eight silk protein cosmetic ingredients in the Fiume and colleagues 2020 paper in the International Journal of Toxicology, concluding that hydrolyzed silk, sericin, and fibroin are safe for use in cosmetic products — the primary regulatory safety reference for this ingredient class.
Silk allergy is a relevant consideration. Individuals with confirmed sensitivity to silk textiles may react to silk protein-derived cosmetic ingredients, although hydrolysis reduces molecular weight and potential allergenicity compared to intact silk proteins. Patch testing is advisable for individuals with known textile protein sensitivities.
Contraindications that apply broadly to this cosmetic peptide category include:
- Known silk protein allergy or sensitivity
- Application to broken or infected skin
- Pregnancy or breastfeeding: no specific reproductive safety data for silk peptide cosmetics; standard cosmetic caution applies; consult a dermatologist
Silk fibroin in biomedical/wound-dressing contexts is a different regulatory category; see relevant product labeling and consult a healthcare provider for medical applications.
What to Test Before Starting Silk Peptides for Skin and Hair
Topical silk peptide cosmetics do not require laboratory testing. However, for individuals whose skin or hair concerns suggest possible nutritional contributors, objective biomarkers can identify correctable factors that topical ingredients cannot address.
- Ferritin: Iron stores marker. Why it matters: Iron deficiency is among the most common reversible causes of hair thinning and impairs collagen synthesis in skin. Ferritin testing identifies this correctable nutritional contributor before attributing hair or skin changes solely to topical ingredient needs.
- Vitamin B12: B12 deficiency is associated with skin and hair changes and impaired cell turnover. Vitamin B12 testing rules out deficiency contributing to skin or hair changes in adults over 40, vegetarians, and others at elevated risk.
- hs-CRP: Systemic inflammation marker. Why it matters: Chronic low-grade inflammation is associated with ECM changes and skin quality changes beyond what topical ingredients can address at the surface. Testing hs-CRP establishes whether systemic inflammation is a relevant contributor that requires addressing upstream.
- Thyroid panel (TSH, free T4): Thyroid dysfunction — both hypothyroidism and hyperthyroidism — causes significant hair and skin changes including hair thinning, dry skin, and altered texture. A thyroid panel rules out this systemic contributor before attributing hair or skin changes to cosmetic ingredient gaps. TSH is available through TSH testing.
Silk peptide cosmetics address the surface biology of skin and hair. Nutritional deficiencies and systemic conditions operate at a level that topical cosmetics cannot reach. Testing establishes where each type of intervention is relevant.
How to Access Silk Peptide Products
Silk peptide ingredients — sericin, fibroin, hydrolyzed silk — are available in over-the-counter cosmetic products including serums, moisturizers, shampoos, conditioners, and hair masks. No prescription is required. Products range from mass-market to specialty skincare formulations.
For individuals interested in the dermatological applications of sericin beyond cosmetics — including wound care or tissue engineering research contexts — these involve medical-grade products under different regulatory pathways and require healthcare provider involvement.
Understanding Your Baseline
Silk peptides occupy a specific position in the cosmetic ingredient landscape: a natural protein-derived category with genuine biological properties documented in vitro, practical cosmetic utility in moisturization and hair conditioning, and an evidence base in human subjects that is less developed than the cellular research suggests possible. The gap between in vitro evidence and clinical trial evidence is the central honest summary of where this ingredient class stands.
For hair thinning and skin quality concerns, the most productive starting point is often understanding what is driving the biology — ferritin, thyroid function, systemic inflammation — before focusing on topical ingredient selection. That testing-first principle is central to Superpower's approach to preventive health.
IMPORTANT NOTICE — COSMETIC INGREDIENTS
The ingredients discussed on this page — silk sericin, silk fibroin, and hydrolyzed silk — are cosmetic ingredients intended for topical application to the skin and hair. Cosmetics are regulated differently from drugs by the FDA. Cosmetic ingredients are not evaluated or approved to diagnose, treat, cure, or prevent any disease or medical condition. The biological properties described in this article — antioxidant, anti-inflammatory, moisture-retaining, and anti-melanogenesis activities — are documented in vitro or in preclinical models; they are not FDA-reviewed claims. This page is provided for educational purposes only and does not constitute medical or dermatological advice.
Silk fibroin used in biomedical wound dressings, surgical scaffolds, or other medical device applications is subject to separate FDA regulatory review as a device. This article does not cover medical device applications of silk materials. Any medical use of silk-based products requires healthcare provider guidance.


.avif)